Lymph node grading study for lung cancer patients
Part of Cancer clinical trials.
This study looks at how lymph node involvement relates to lung cancer outcomes. It uses tissue samples and medical records from patients who had surgery at Fudan University Shanghai Cancer Center between 2011 and 2021.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with invasive lung adenocarcinoma (a common type of lung cancer).
- You had surgery to remove the tumor at Fudan University Shanghai Cancer Center between January 2011 and September 2021.
- Your cancer was not adenocarcinoma in situ, minimally invasive adenocarcinoma, invasive mucinous adenocarcinoma, or other rare types.
- You have complete results for common genetic mutations in the tumor (like EGFR or ALK).
- Your original pathology slides are available for review.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a more focused lymph node removal during surgery is safe and effective for people with a small, early-stage lung cancer (non-small cell type) located in the top part of the lung (apical segment).
This trial is testing a lung-sparing surgery called segmentectomy for people with a certain type of lung cancer nodule. It aims to see if this surgery is a good option for those with solid-dominant nodules that are 2 to 3 cm in size and have not spread to lymph nodes.
This study looks at inherited genetic changes in people with a type of lung cancer called lung adenocarcinoma. The goal is to find gene variants linked to the disease, which may help guide future treatment decisions.
This study looks for biological markers (signs in blood or tissue) that predict how early-stage lung cancer spreads. If you have recently diagnosed lung cancer, this research could help doctors better understand your cancer and plan better treatments.
This study looks at the characteristics, treatments, and results of people who have had surgery to remove lung cancer. It aims to help doctors understand what happens after surgery.
This study looks at whether different lymph node removal methods during lung surgery change outcomes for certain abnormal lung spots. It focuses on ground-glass nodules that stay the same after treatment-free observation and have a mostly solid portion on CT.
Hear when a new Lung Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.